In insurance M&A, what kills a deal depends on who you ask. Valuation gaps, execution risk, and regulation collide behind closed doors, turning strategy into stalemate.
In a fragmented insurance M&A landscape, strategic consensus is in short supply
Insurance M&A is set for another active year, but the motivations behind deals are becoming more fragmented across executive levels.
In our latest Insurance150 microsurvey, we asked executives across the industry a pivotal question: “How likely is your organization to pursue M&A in the next 24 months?”